Edu Butyrose
  • Responsabile scientifico
  • Articoli
    • BARRIERA EPITELIALE INTESTINALE
    • BUTIRRATO
    • COVID-19
    • GVHD – Graft-versus-Host Disease / Malattia del trapianto contro l’ospite
    • IBS
    • IBD
    • IDROSADENITE SUPPURATIVA
    • LINEE GUIDA
    • MALATTIE METABOLICHE
    • MALATTIA DIVERTICOLARE
    • RADIOTERAPIA
    • RIGENERAZIONE CUTANEA
  • Interviste
  • Eventi
  • Studi in corso
  • Riviste
  • Documenti utili
  • LSC
  • SILA
  • Logout
Seleziona una pagina

Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals Aftab Ahmad, Wanwei Yang, Guofang Chen, Muhammad Shafiq, Sundus Javed, Syed Shujaat Ali Zaidi, Ramla Shahid, Chao Liu, Habib BokhariI Visualizza...

A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents Sofa Moran‑Ramos , Luis Macias‑Kaufer, Blanca E. López Contreras, Hugo Villamil‑Ramírez, Elvira Ocampo‑Medina, Paola...

Effects of a Low-Fat Vegan Diet on Gut Microbiota in Overweight Individuals and Relationships with Body Weight, Body Composition, and Insulin Sensitivity.

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

Effects of a Low-Fat Vegan Diet on Gut Microbiota in Overweight Individuals and Relationships with Body Weight, Body Composition, and Insulin Sensitivity. Hana Kahleova, Emilie Rembert, Jihad Alwarith, Willy N. Yonas, Andrea Tura, Richard Holubkov, Melissa Agnello,...

The efect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

The efect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial Yi-Yuan Sun, Ming Li, Yue-Yue Li, Li-Xiang Li, Wen-Zhe Zhai, Peng Wang, Xiao-Xiao Yang, Xiang Gu,...

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

da admin | Nov 14, 2023 | RACCOLTA BIBLIOGRAFICA

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease Sonia Facchin, Nicola Vitulo,Matteo Calgaro, Andrea Buda, Chiara Romualdi, Daniel Pohl, Barbara Perini, Greta Lorenzon, Carla Marinelli, Renata D’Incà, Giacomo...
« Post precedenti
Post successivi »

Articoli recenti

  • Global guidelines on diverticular disease of the colon: the Fiesole Consensus report
  • Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain
  • Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease
  • Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study
  • Rifaximin in diverticulosis and diverticular disease: a national survey among Italian gastroenterologists and general practitioners

Commenti recenti

    ideA-Z Project in progress S.r.l. | P.IVA: IT03373190960
    Corso Giacomo Matteotti, 48 – 20081 – Abbiategrasso (MI) | info@idea-z.it